Edges in Network
| Network | GSE5851_egf1520 - GSE5851 - SiGN-BN HC+Bootstrap |
| Network Description | Phase II exploratory pharmacogenomics study of cetuximab monotherapy in patients with advanced metastatic CRC |
| Node | KLK10 |
| Upstream (Parents) |
|---|
| (<<) ANXA2 → KLK10 |
| (<<) CXCL1 → KLK10 |
| (<<) CXCL3 → KLK10 |
| (<<) ENO2 → KLK10 |
| (<<) EPHA2 → KLK10 |
| (<<) HBEGF → KLK10 |
| (<<) ITGB4 → KLK10 |
| (<<) JUNB → KLK10 |
| (<<) PLAUR → KLK10 |
| (<<) S100A2 → KLK10 |
| (<<) S100P → KLK10 |
| (<<) SERPINB1 → KLK10 |
| (<<) SFN → KLK10 |
| (<<) TAGLN2 → KLK10 |
| (<<) TSPO → KLK10 |
| Downstream (Children) |
|---|
| KLK10 → EFNB2 (>>) |
| KLK10 → EPHA4 (>>) |
| KLK10 → FGFBP1 (>>) |
| KLK10 → FOSL1 (>>) |
| KLK10 → HLA-G (>>) |
| KLK10 → IL18 (>>) |
| KLK10 → KCNK1 (>>) |
| KLK10 → KLK7 (>>) |
| KLK10 → KLK8 (>>) |
| KLK10 → KRT6B (>>) |
| KLK10 → MLPH (>>) |
| KLK10 → MMP7 (>>) |
| KLK10 → RHOC (>>) |
| KLK10 → SERPINB5 (>>) |
| KLK10 → SPRR3 (>>) |
| KLK10 → TFF1 (>>) |
| KLK10 → TGM2 (>>) |
| KLK10 → TTC9 (>>) |
| KLK10 → VTCN1 (>>) |
| KLK10 → YWHAH (>>) |
